Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting
about
Enhancing oral vaccine potency by targeting intestinal M cellsParenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infectionThe gut wall provides an effective barrier against nanoparticle uptakeCoating with luminal gut-constituents alters adherence of nanoparticles to intestinal epithelial cellsMolecular evolution of peptide ligands with custom-tailored characteristics for targeting of glycostructuresModulation of ocular surface glycocalyx barrier function by a galectin-3 N-terminal deletion mutant and membrane-anchored synthetic glycopolymersThe effects of orally administered Beta-glucan on innate immune responses in humans, a randomized open-label intervention pilot-studyComparative analysis of EspF variants in inhibition of Escherichia coli phagocytosis by macrophages and inhibition of E. coli translocation through human- and bovine-derived M cells.Intestinal M cells: the fallible sentinels?The bovine milk microbiota: insights and perspectives from -omics studies.Botulinum toxin A complex exploits intestinal M cells to enter the host and exert neurotoxicity.Starch microparticles as oral vaccine adjuvant: antigen-dependent uptake in mouse intestinal mucosa.Interactions of viruses and microparticles with apical plasma membranes of M cells: implications for human immunodeficiency virus transmission.Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins.Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosageRole of intimin and bundle-forming pili in enteropathogenic Escherichia coli adhesion to pediatric intestinal tissue in vitroBordetella pertussis filamentous hemagglutinin enhances the immunogenicity of liposome-delivered antigen administered intranasally.Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system.Secretory immunoglobulin A: from mucosal protection to vaccine development.Active and selective transcytosis of cell-free human immunodeficiency virus through a tight polarized monolayer of human endometrial cellsMucin-related epitopes distinguish M cells and enterocytes in rabbit appendix and Peyer's patches.Human intestinal M cells display the sialyl Lewis A antigen.Glycocalyx on rabbit intestinal M cells displays carbohydrate epitopes from Muc2Unsolved mysteries of intestinal M cells.Combination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes.Targeted disruption of core 1 β1,3-galactosyltransferase (C1galt1) induces apical endocytic trafficking in human corneal keratinocytes.Propensity to high-fat diet-induced obesity in mice is associated with the indigenous opportunistic bacteria on the interior of Peyer's patches.Vaccine adjuvants: current state and future trends.The biology of intestinal immunoglobulin A responsesImmunoglobulin A antibodies against ricin A and B subunits protect epithelial cells from ricin intoxicationSalmonella Interaction with and Passage through the Intestinal Mucosa: Through the Lens of the OrganismThe viral sigma1 protein and glycoconjugates containing alpha2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces.Transcytosis: crossing cellular barriers.Contribution of microbiota to the intestinal physicochemical barrier.Breast milk, microbiota, and intestinal immune homeostasis.The development of M cells in Peyer's patches is restricted to specialized dome-associated cryptsUse of targeting agents to increase uptake and localization of drugs to the intestinal epithelium.Improving M cell mediated transport across mucosal barriers: do certain bacteria hold the keys?Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination.Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
P2860
Q21089613-EDB94AC6-7E37-4FC3-A477-C5F5ACC55BFEQ24548763-D6A81765-A011-4C2A-A054-524CB53B4C63Q28384695-7A7D422A-573F-49A6-9034-C783EDC5691FQ28384704-E6FFCE15-2B3D-44A1-9489-E13FA2E5B0DBQ28484348-A233C355-7ED2-4F8A-9B50-A0099623046BQ28535428-DB67BEE4-FBA4-4807-A076-D6178D409A31Q28543440-8CCCCDB3-23AF-40E0-9013-D0F64E31662AQ30010247-E5EF019F-2915-4338-BDEC-E324CC3E515DQ30050457-CED025EF-24CB-4734-9172-994BB29AFB37Q30250211-C7D06749-452D-4942-9AA8-B8DAABD70FF8Q30621197-2CAF3653-0A77-4C36-8760-D8F07E8C3526Q33208470-AB772D96-B6EC-4BC3-8552-EBA339FB400FQ33547143-B3771BA2-8BD1-46DF-B5AA-32C2D72EEE4AQ33547146-85B355C8-6CDE-4831-8FAF-C69CE5D80B26Q33595830-E4E92AAC-A9B0-4BCF-86E7-0BFBF5F19EBEQ33752405-BA4421E0-BF59-4313-9A41-86914B4D649AQ33752750-3631A706-C6B2-4AD5-9B44-5F5D2A3FF6D2Q33762159-A40FC7CF-7864-43F5-BB05-07718F364428Q33805948-1C86B100-A273-4D4A-B9A0-F6FD459AA277Q33852171-B32D98DA-0BA1-40D1-BC50-3A8418685262Q34000056-CBE09E5E-0AA1-40F3-AEE3-C378B901EF7BQ34000445-70214FDD-FC9F-4D51-B32A-0B7937E8249AQ34006064-CC2BF83D-9033-48F8-A6BE-0A5E4309252FQ34061983-E959E1CE-BD6C-4F6A-A092-A9A2AA83FE05Q34119423-04734BE0-0CC1-4C08-907D-6621D51EF423Q34264840-22AB0327-1B94-418C-871F-BC2D9B565220Q34292401-EDF91D0C-B256-4EBB-9527-1CA9F6E4A480Q34358206-3A305B48-8075-4D52-97E1-157E9ABB5478Q34673861-C03F2F58-3299-4EBD-A872-C6A537743CAAQ34681058-6688B989-940D-46DC-BCA8-E407AA80D158Q35084574-A14119BC-09DB-4027-96F7-75B5B9B2D210Q35104539-ADFA75FF-08A8-4745-8EE2-3335A42BCF4DQ35169907-F322B997-4BE6-4C3E-BACB-60F5B8640719Q35292478-6446666F-0EB5-47AD-92C1-FB6ED6AA5577Q35327381-3782A6B7-A2D2-43C7-84DE-C1BFFFA80373Q35787033-EA340827-8750-4AF4-B826-357CA36C8E3FQ35809229-7AC2224D-3EAD-4722-9C3C-5047B147CD1FQ35863373-E7119025-E19E-462E-BF6B-A41FE7C70257Q35865115-B179EF1A-BA78-4D6F-B4C6-CC48628A2453Q35877982-3B9FF09C-433D-4141-AE0E-4B8FF1AD2584
P2860
Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting
description
1996 nî lūn-bûn
@nan
1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Role of the glycocalyx in regu ...... ent and oral vaccine targeting
@ast
Role of the glycocalyx in regu ...... ent and oral vaccine targeting
@en
Role of the glycocalyx in regu ...... ent and oral vaccine targeting
@nl
type
label
Role of the glycocalyx in regu ...... ent and oral vaccine targeting
@ast
Role of the glycocalyx in regu ...... ent and oral vaccine targeting
@en
Role of the glycocalyx in regu ...... ent and oral vaccine targeting
@nl
prefLabel
Role of the glycocalyx in regu ...... ent and oral vaccine targeting
@ast
Role of the glycocalyx in regu ...... ent and oral vaccine targeting
@en
Role of the glycocalyx in regu ...... ent and oral vaccine targeting
@nl
P2093
P2860
P356
P1476
Role of the glycocalyx in regu ...... ent and oral vaccine targeting
@en
P2093
K T Giannasca
M R Neutra
P J Giannasca
W I Lencer
P2860
P304
P356
10.1084/JEM.184.3.1045
P407
P577
1996-09-01T00:00:00Z